ArticleCellular and molecular life sciences : CMLS2025
Hypoxia-inducible factor 2 triggers the production of highly infectious native-like hepatitis C virus particles.
Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
We recently developed an original HCV-permissive cell culture model based on both partial differentiation and physiological oxygen pressure (Hypo-Diff cells) that produces highly infectious lipid-rich and native-like HCV-lipoviroparticles (LVPs). Here, we explored the precise role of physiological hypoxia and related specific transcription factors, hypoxia-inducible factors 1α and 2α (HIF-1α and HIF-2α) to better understand the mechanism governing viral morphogenesis. Knocking-down HIF-2α specifically reduced both the number and size of neutral lipid-rich droplets in Huh7.5 Hypo-Diff cells, suggesting a central role for HIF-2 in controlling lipid metabolism under physiological hypoxia. In HCV-infected siHIF-2α Hypo-Diff cells, both HCV replication and the specific infectious viral efficacy of progeny viruses were significantly impaired. Interestingly, the ectopic expression of a mutated form of the HIF-2α protein, stabilized in normoxia, both increased the number and size of neutral lipid-rich droplets and restored the production of highly infectious HCV viruses in the absence of cell differentiation. Finally, by iodixanol fractionation of supernatants to determine the mean buoyant density of infectious HCV LVPs, we established that HIF-2α is exclusively responsible for producing highly lipidated and broadly infectious HCV-LVPs by Hypo-Diff cells. These findings thus clearly establish the central role of physiological hypoxia, and notably HIF-2, in the production of highly infectious lipid-rich native-like HCV particles. Since physiological hypoxia is a shared characteristic in mammalian tissues, we propose to reconsider the role of natural oxygen tension and especially the role of HIF-2 in the life cycle of other lipid-associated viruses, whether hepatotropic or not.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.